This study describes a methodology for generating stable, cloned, EBV-transformed IgG-and IgM-producing human B cell lines. Using these lines we have characterized immunoglobulin V gene utilization in an anti-DNA-associated idiotypic system. The 31 anti-DNA-associated idiotype is encoded preferentially by the VKl gene family, and, in all probability, reflects a germ line gene-encoded framework determinant. Analysis of these lines indicates that the DNA-binding antibodies produced by B cell lines from SLE patients may differ from DNA binding myeloma proteins and from natural autoantibodies. (J. Clin. Invest. 1991. 87:1519-1525.) Key words: clonal EBV lines * anti-DNA idiotype * systemic lupus erythematosus * autoantibody Introduction Little is known about the etiology of autoantibody production in systemic lupus erythematosus (SLE),I and animal models of the disease have led to disparate views. Many ofthe manipulations performed in studies of lupus-prone mice clearly cannot be undertaken in studies ofthe human disease; nonetheless, the study of the autoantibodies themselves can be very revealing. Serologic studies of SLE have employed idiotypic analyses to identify and characterize subsets of autoantibodies that bind DNA and structurally related antibodies that do not bind DNA. One approach has been to generate antiidiotypic reagents to monoclonal anti-DNA antibodies. However, it is not clear how closely the selected monoclonal autoantibodies mirror the pathogenic anti-DNA antibodies in disease. The approach favored by our laboratory has been to generate antiidiotypes to the heterogenous anti-DNA antibodies present in the serum and kidneys of individuals with SLE. The 3I antiidiotype recognizes a determinant on kappa light chains of anti-DNA antibodies (1). High titered expression of31-reactive antibodies is present in -80% of SLE patients with anti-DNA activity. We studied expression of the 31 idiotype in the serum ofrelatives ofSLE patients, as well as on monoclonal immunoglobulins in the serum of individuals with monoclonal gammopathies (1, 2) to obtain structural and genetic information